Faculty of Medicine

Organisational unit: Faculty

More filtering options
  1. Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.

    Jenny Öhman, Gunilla Nordin Fredrikson, Lisa Berglund, Carin Gustavsson, Eva Bengtsson, Maj-Lis Smith, Carl-David Agardh, Elisabet Agardh, Stefan Jovinge, Maria Gomez & Jan Nilsson, 2009, In : Arteriosclerosis, Thrombosis and Vascular Biology. 29, 10, p. 1465-1470

    Research output: Contribution to journalArticle

  2. Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis A nationwide population-based cohort study

    Pauline Raaschou, Jonas Söderling, Carl Turesson, Johan Askling & ARTIS Study Group ARTIS Study Group, 2018 Sep 4, In : Annals of Internal Medicine. 169, 5, p. 291-299 9 p.

    Research output: Contribution to journalArticle

  3. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis.

    Robert Iosif, Christine T Ekdahl, Henrik Ahlenius, Cornelis J H Pronk, Sara Bonde, Zaal Kokaia, Sten Eirik W Jacobsen & Olle Lindvall, 2006, In : Journal of Neuroscience. 26, 38, p. 9703-9712

    Research output: Contribution to journalArticle

  4. Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors.

    Kees-Jan Pronk, Ole Petter Veiby, David Bryder & Sten Eirik W Jacobsen, 2011, In : Journal of Experimental Medicine. 208, 8, p. 1563-1570

    Research output: Contribution to journalArticle

  5. Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis

    Giovanni Cagnotto, Michele Compagno, Carlo Alberto Scire & Matteo Bruschettini, 2020 May 18, In : Cochrane Database of Systematic Reviews. 2020, 5, CD013614.

    Research output: Contribution to journalReview article

  6. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells

    Ingunn Dybedal, David Bryder, Anna Fossum, Leiv S. Rusten & Sten Eirik W Jacobsen, 2001, In : Blood. 98, 6, p. 1782-1791

    Research output: Contribution to journalArticle

  7. Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    Dimitrios Zardavas, Luc Te Marvelde, Roger L. Milne, Debora Fumagalli, George Fountzilas, Vassiliki Kotoula, Evangelia Razis, George Papaxoinis, Heikki Joensuu, Mary Ellen Moynahan, Bryan T. Hennessy, Ivan Bieche, Lao H. Saal, Olle Stal, Barry Iacopetta, Jeanette Dupont Jensen, Sandra O'Toole, Elena Lopez-Knowles, Mattia Barbaraeschi, Shinzaburo Noguchi & 12 others, Hatem A. Azim, Enrique Lerma, Thomas Bachelot, Qing Wang, Gizeh Perez-Tenorio, Cornelis J.H. Can De Velde, Daniel W. Rea, Vicky Sabine, John M.S. Bartlett, Christos Sotiriou, Stefan Michiels & Sherene Loi, 2018 Jan 1, In : Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journalArticle

  8. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling

    M. Herzig, F. Savarese, M. Novatchkova, Henrik Semb & G Christofori, 2007, In : Oncogene. 26, 16, p. 2290-2298

    Research output: Contribution to journalArticle

  9. Tumor Regression and Cure Depends on Sustained Th1 Responses

    Min Dai, Ingegerd Hellstrom, Yuen Y. Yip, Hans Olov Sjögren & Karl Erik Hellstrom, 2018, In : Journal of Immunotherapy. 41, 8, p. 369-378

    Research output: Contribution to journalArticle

  10. Tumors associated with Hereditary Nonpolyposis Colorectal Cancer: Defective Mismatch Repair and Familial Risk of Cancer

    Kajsa Ericson Lindquist, 2005, Department of Oncology, Clinical Sciences, Lund University. 120 p.

    Research output: ThesisDoctoral Thesis (compilation)

  11. Tumor Selective Antiproliferative Naphthoxylosides

    Ulrika Aili, 2013, Glycobiology, Dept of Experimental Medical Science. 94 p.

    Research output: ThesisDoctoral Thesis (compilation)

  12. Tumor Size of Invasive Breast Cancer on Magnetic Resonance Imaging and Conventional Imaging (Mammogram/Ultrasound): Comparison with Pathological Size and Clinical Implications.

    Kristin Huld-Haraldsdottir, Þ Jónsson, AB Halldórsdóttir, Karl-Göran Tranberg & KS Ásgeirsson, 2016, In : Scandinavian Journal of Surgery. 106, 1, p. 68-73

    Research output: Contribution to journalArticle

  13. Tumors of bone

    Fredrik Mertens & Nils Mandahl, 2015, Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. Heim, S. & Mitelman, F. (eds.). 4th ed. Wiley-Blackwell, p. 566-582 17 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  14. Tumors of endocrine glands

    Jörn Bullerdiek & David Gisselsson, 2015, Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. Heim, S. & Mitelman, F. (eds.). 4th ed. Wiley-Blackwell, p. 497-514 18 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  15. Tumors of the skin

    Fredrik Mertens, Felix Mitelman & Sverre Heim, 2015, Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. Heim, S. & Mitelman, F. (eds.). 4th ed. Wiley-Blackwell, p. 555-565 11 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  16. Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.

    Emma Gustbée, Helga Tryggvadottir, Andrea Markkula, Maria Simonsson, Björn Nodin, Karin Jirström, Carsten Rose, Christian Ingvar, Signe Borgquist & Helena Jernström, 2015, In : BMC Clinical Pathology. 15, 8.

    Research output: Contribution to journalArticle

  17. Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.

    Donal J Brennan, Henriette Laursen, Darran P O'Connor, Signe Borgquist, Mathias Uhlen, William M Gallagher, Fredrik Pontén, Robert C Millikan, Lisa Rydén & Karin Jirström, 2011, In : Breast Cancer Research. 13, 1, p. 1-12

    Research output: Contribution to journalArticle

  18. Tumor Specific Migration Of Bone-Marrow Derived Rat Mesenchymal Stem Cells In The Invasive N29 Rat Brain Tumor Model

    Daniel Bexell, Salina Gunnarsson, Ariane Tormin, David Gisselsson Nord, Stefan Scheding & Johan Bengzon, 2008, In : Neuro-Oncology. 10, 6, p. 1066-1066

    Research output: Contribution to journalPublished meeting abstract

  19. Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.

    Lisa Rydén, Maria Stendahl, Håkan Jonsson, Stefan Emdin, Nils O Bengtsson & Göran Landberg, 2005, In : Breast Cancer Research and Treatment. 89, 2, p. 135-143

    Research output: Contribution to journalArticle

  20. Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer

    L Ryden, B Linderholm, NH Nielsen, S Emdin, PE Jonsson & Göran Landberg, 2003, In : Breast Cancer Research and Treatment. 82, 3, p. 147-154

    Research output: Contribution to journalArticle

  21. Tumor stiffness extends its grip on the metastatic microenvironment

    Steven E. Reid & Sara Zanivan, 2017 Nov 2, In : Molecular and Cellular Oncology. 4, 6, e1372866.

    Research output: Contribution to journalArticle